The Drug Development and Active Substance Testing Group at the National Laboratory of Virology, University of Pécs, is at the forefront of studying and developing antiviral agents, with a special emphasis on UV inactivation techniques and their virological applications. Combining expert biosafety knowledge and virological expertise, our team extensively researches emerging and significant viruses across biosafety levels BSL-2, BSL-3, and BSL-4. We are pioneers in developing therapeutically viable newly synthesized active substances, repurposing existing pharmaceutical treasures, and other compounds like monoclonal antibodies in the innovative fight against viral infections. Our primary objective is to initiate the development of rapidly deployable medications that can effectively combat epidemics. Committed to advancing scientific knowledge, the Drug Development and Active Substance Testing Group at the National Laboratory of Virology, University of Pécs, focuses on discovering suitable active ingredients for use in antiviral medications, marking the first step in the development of antiviral drugs.